Vimarsana
Biggest News Aggregation in the World

Netcapital Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Netcapital Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Netcapital Inc Today - Breaking & Trending Today

Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Applied DNA Sciences (NASDAQ:APDN) - Vimarsana News

Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Applied DNA Sciences (NASDAQ:APDN)

Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - NVIDIA (NASDAQ:NVDA) - Vimarsana News

Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - NVIDIA (NASDAQ:NVDA)

Insider Buying: Netcapital Inc. (NASDAQ:NCPL) Director Purchases 239,274 Shares of Stock - Vimarsana News

Insider Buying: Netcapital Inc. (NASDAQ:NCPL) Director Purchases 239,274 Shares of Stock

Netcapital Inc. (NASDAQ:NCPL – Get Free Report) Director Steven F. Geary purchased 239,274 shares of the firm’s stock in a transaction on Wednesday, April 24th. The stock was bought at an average price of $0.13 per share, for a total transaction of $31,105.62. Following the purchase, the director now owns 249,574 shares in the company, […]

Source: wkrb13.com
Vivakor And 2 Other Stocks Under $5 Insiders Are Buying - Vivakor (NASDAQ:VIVK) - Vimarsana News

Vivakor And 2 Other Stocks Under $5 Insiders Are Buying - Vivakor (NASDAQ:VIVK)

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Allarity Therapeutics (NASDAQ:ALLR) - Vimarsana News

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Allarity Therapeutics (NASDAQ:ALLR)

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.